BG
REGN icon

BlackRock Group’s Regeneron Pharmaceuticals REGN Stock Holding History

BlackRock Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$233M Buy
634,545
+18,328
+3% +$6.97M 0.11% 222
2016
Q3 		$248M Buy
616,217
+17,764
+3% +$7.13M 0.12% 196
2016
Q2 		$209M Buy
598,453
+15,934
+3% +$6.14M 0.11% 229
2016
Q1 		$210M Sell
582,519
-20,846
-3% -$8.59M 0.11% 204
2015
Q4 		$328M Sell
603,365
-9,885
-2% -$5.36M 0.18% 131
2015
Q3 		$285M Sell
613,250
-51,051
-8% -$27.4M 0.17% 142
2015
Q2 		$339M Buy
664,301
+29,841
+5% +$14.6M 0.18% 120
2015
Q1 		$286M Sell
634,460
-3,545
-0.6% -$1.5M 0.15% 148
2014
Q4 		$262M Buy
638,005
+30,831
+5% +$12.1M 0.14% 169
2014
Q3 		$219M Sell
607,174
-24,762
-4% -$8.3M 0.13% 184
2014
Q2 		$179M Buy
631,936
+53,466
+9% +$15.8M 0.1% 239
2014
Q1 		$174M Buy
578,470
+40,664
+8% +$12.5M 0.11% 221
2013
Q4 		$148M Sell
537,806
-28,907
-5% -$8.31M 0.1% 242
2013
Q3 		$177M Buy
566,713
+48,085
+9% +$12.6M 0.12% 190
2013
Q2 		$117M Buy
+518,628
New +$121M 0.09% 258

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock Group's REGN Position: Q4 2016 in Review

BlackRock Group increased its Regeneron Pharmaceuticals (REGN) stake by 3% in Q4 2016, buying an estimated $6.97M and bringing the position to 634,545 shares worth $233M. The position accounts for 0.11% of the portfolio, ranked #222.

BlackRock Group first reported a position in REGN in Q2 2013 and has held it in 15 quarters since. The position peaked at $339M in Q2 2015. 576 funds tracked by Wall St. Rank hold REGN as of Q4 2016.

  • BlackRock Group held 634,545 shares of Regeneron Pharmaceuticals worth $233M as of Q4 2016.
  • BlackRock Group bought 18,328 Regeneron Pharmaceuticals shares in Q4 2016, an estimated $6.97M.
  • Regeneron Pharmaceuticals made up 0.11% of BlackRock Group's portfolio in Q4 2016, its #222 holding.
  • BlackRock Group first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's Regeneron Pharmaceuticals position peaked at $339M in Q2 2015.
  • 576 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.